Skip to main content
. 2017 Dec 4;8(66):110326–110336. doi: 10.18632/oncotarget.22887

Table 7. Stratified analyses between MTHFR rs4846048 A>G polymorphism and NSCLC risk by sex, age, BMI, smoking status and alcohol consumption.

Variable MTHFR rs4846048 A>G (case/control)a Adjusted ORb (95% CI); P
AA AG GG AA AG GG AG/GG GG vs. (AG/AA)
Sex
Male 233/488 51/88 3/11 1.00 1.29(0.86-1.94);P: 0.221 0.68(0.18-2.64);P: 0.576 1.22(0.83-1.81);P: 0.314 0.65(0.17-2.52);P: 0.535
Female 195/361 39/77 0/4 1.00 0.97(0.63-1.49);P: 0.884 - 0.92(0.60-1.41);P: 0.701 -
Age
< 60 191/393 47/74 0/8 1.00 1.45(0.95-2.22);P: 0.088 - 1.32(0.87-2.00);P: 0.197 -
≥ 60 237/456 43/91 3/7 1.00 0.88(0.59-1.33);P: 0.555 0.94(0.23-3.86);P: 0.936 0.89(0.60-1.32);P: 0.558 0.96(0.24-3.93);P: 0.959
Smoking status
Never 262/676 53/140 2/11 1.00 0.98(0.69-1.40);P: 0.925 0.60(0.13-2.79);P: 0.512 0.96(0.68-1.36);P: 0.810 0.60(0.13-2.79);P: 0.513
Ever 166/173 37/25 1/4 1.00 1.54(0.89-2.68);P: 0.126 0.31(0.03-2.87);P: 0.302 1.39(0.81-2.36);P: 0.230 0.29(0.03-2.67);P: 0.274
Alcohol consumption
Never 366/779 76/156 2/13 1.00 1.06(0.77-1.45);P: 0.723 0.41(0.09-1.89);P: 0.254 1.01(0.75-1.38);P: 0.931 0.41(0.09-1.87);P: 0.248
Ever 62/70 14/9 1/2 1.00 1.95(0.77-4.96);P: 0.162 0.57(0.05-7.23);P: 0.664 1.70(0.71-4.09);P: 0.238 0.52(0.04-6.52);P: 0.610
BMI(kg/m2)
< 24 281/455 55/86 1/5 1.00 1.10(0.75-1.62);P: 0.629 0.55(0.06-4.92);P: 0.591 1.08(0.74-1.57);P: 0.708 0.54(0.06-4.83);P: 0.579
≥ 24 147/394 35/79 2/10 1.00 1.20(0.76-1.89);P: 0.433 0.41(0.08-2.02);P: 0.274 1.10(0.71-1.71);P: 0.678 0.40(0.08-1.96);P: 0.258

aThe genotyping was successful in 521 (100.00%) NSCLC cases, and 1030 (99.90%) controls for MTHFR rs4846048 A>G;

bAdjusted for age, sex, BMI, smoking status and alcohol consumption (besides stratified factors accordingly) in a logistic regression model.